Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

79.77
Delayed Data
As of Aug 26
 -0.31 / -0.39%
Today’s Change
77.92
Today|||52-Week Range
113.31
-21.17%
Year-to-Date
10 Undervalued Stocks for the Enterprising Investor
Aug 26 / GuruFocus News - Paid Partner Content
3 Reasons Gilead Sciences Inc. Stock Could Fall
Aug 25 / MotleyFool.com - Paid Partner Content
Gilead (GILD) Stock Lower, Citigroup: Hepatitis C Drug Sales Look Weak
Aug 26 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review
Aug 24 / Zacks.com - Paid Partner Content
3 Top Stocks to Buy for Your Children
Aug 26 / MotleyFool.com - Paid Partner Content
Gilead Sciences (GILD) Stock Price Target Cut, Leerink: Weak HIV Sales
Aug 24 / TheStreet.com - Paid Partner Content
'Mad Money' Lightning Round: I Can't Recommend Gilead
Aug 26 / TheStreet.com - Paid Partner Content
Why You Should (and Shouldn't) Buy Gilead Sciences, Inc.
Aug 24 / MotleyFool.com - Paid Partner Content
Stock Market News for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
Gilead (GILD) Truvada Gets EU Approval for Label Expansion
Aug 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close80.08
Today’s open80.11
Day’s range79.27 - 80.33
Volume8,928,026
Average volume (3 months)10,191,851
Market cap$105.7B
Dividend yield2.36%
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-6.60%
Earnings growth (next 5 years)-1.30%
Revenue growth (last year)+28.71%
P/E ratio7.0
Price/Sales4.80
Price/Book6.14

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+1.74+1.02%
BIIBBiogen+1.32+0.43%
BAXBaxter International...+0.08+0.17%
ILMNIllumina Inc+2.73+1.61%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$2.88
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs